Alfred Ian Lee, MD, PhD

Assistant Professor of Medicine (Hematology); Firm Chief, Inpatient Hematology, Yale Cancer Center; Assistant Program Director, Traditional Internal Medicine Residency Program

Patient Care

Accepts new patients? Yes
Patient Type: Adult
Referrals: From patients or physicians

Patient Care Organizations

Cancer Center, Yale: Hematology Program

Internal Medicine: Hematology

Yale Medical Group

Board Certifications

  • Internal Medicine AB of Internal Medicine (2007)

  • Hematology (Internal Medicine) AB of Internal Medicine (2013)

Clinical Trials

Conditions Study Title
Myeloid and Monocytic Leukemia A Randomized Phase III Study of Standard Cytarabine Plus Daunomycin (7+3) Therapy versus Idarubicin with High Dose Cytarabine (IA) with or without Vorinostat (IA+V) in Younger Patients with Previously Untreated Acute Myeloid Leukemia (AML)
Leukemia, not otherwise specified, Leukemia, other, Myeloid and Monocytic Leukemia A Phase 1 Study of Ipilimumab in relapsed and refractory high risk myelodysplastic syndrome and acute myeloid leukemia with minimal residual disease
Myeloid and Monocytic Leukemia A Phase 3 Open-Label Randomized Study of Quizartinib (AC220) Monotherapy Versus Salvage Chemotherapy in Subjects with FLT3-ITD Positive Acute Myeloid Leukemia (AML) Refractory To or Relapsed After First-line Treatment With or Without Hematopoietic Stem Cell Transplantation (HSCT) Consolidation
Myeloid and Monocytic Leukemia A Randomized, Open Label, Phase 2 Study of the Selective Inhibitor of Nuclear Export (SINE) Selinexor (KPT-330) Versus Specified Physician's Choice in Patients ≥ 60 Years Old With Relapsed/Refractory AML Who Are Ineligible for Intensive Chemotherapy and/or Transplantation
Prospective Randomized Double-Blind, Placebo Controlled Evaluation of the Pharmacokinetics, Safety and Efficacy of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia (PRESERVE-1)
Comparison of Gut Commensal Bacteria Between Persistently anti-gamma2 Glycoprotein-I Positive Patients and Antiphospholipid Antibody Negative Patients
Unknown Sites Specimen Repository for Hematologic Diseases
An ascending single dose study to evaluate the safety, tolerability and pharmacokinetics/pharmacodynamics of PF-05280602, a recombinant factor VIIa variant (813D), in adult hemophilia A and B subjects with or without inhibitors.
Unknown Sites Study of Immune System in Patients with Cancer and Blood Disorders
Hodgkin's Lymphoma, Leukemia, not otherwise specified, Multiple Myeloma, Non-Hodgkin's Lymphoma Defibrotide for Patients with Hepatic Veno-Occlusive Disease (VOD): A Treatment IND Study

Edit this profile

Contact Info

Alfred Ian Lee, MD, PhD
Patient Care Location
Yale HematologySmilow Cancer Hospital at Yale - New Haven
35 Park Street, Ste North Pavilion 7

New Haven, CT 06511
Mailing Address
PO Box 208021
New Haven, CT 06520-8021